Skip to content

Clinical trials

Phase 2/3 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 2/3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20051
20061
20082
20091
20101
20111
20122
20132
20191
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status6
Terminated4
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federation Francophone de Cancerologie Digestive2
RenJi Hospital2
Asan Medical Center1
Auron Healthcare GmbH1
Cure&Sure Biotech Co., LTD1
Eastern Hepatobiliary Surgery Hospital1
FeRx1
Fudan University1
Guangxi Medical University1
Ivy Life Sciences, Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms20
Carcinoma, Hepatocellular10
Lung Neoplasms3
Colonic Neoplasms2
Gallbladder Neoplasms2
Gastrointestinal Neoplasms2
Neoplasms2
Pancreatic Neoplasms2
Prostatic Neoplasms2
Stomach Neoplasms2

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.